Navigation Links
Global Molecular Biology Enzymes, Kits, & Reagents (Cloning, Epigenetics, PCR, Restriction Digestion, Sequencing) Market - Forecast to 2018

DUBLIN, Aug. 22, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Molecular Biology Enzymes, Kits, & Reagents (Cloning, Epigenetics, PCR, Restriction Digestion, Sequencing) Market - Forecast to 2018" report to their offering.

The global molecular biology enzymes market was valued at $2,847.63 million in 2013, and is expected to grow at a CAGR of 13.74% to reach $5,420.63 million in 2018. Molecular biology enzymes, kits, & reagents find applications in a large number of fields in life science research. They also find application in diagnostics and drug discovery research. These products are widely used for analysis of cell surface markers, which can act as diagnostics or therapeutic targets. PCR (polymerase chain reactions) is one of the most widely-used analytical and preparative techniques in molecular biology. It finds applications in large numbers of experimental procedures, like preparative PCR, RT-PCR, qPCR, and so on. As such, it is one of the largest application segments of the molecular biology enzymes market in 2013. PCR also finds applications in diagnostics, gene expression, and DNA fingerprinting.

This report provides a granular understanding of the molecular biology enzymes, kits & reagents market. This report segments the global molecular market on the basis of applications, end users, products and geographies. The application segments included in this report are cloning, epigenetics, PCR, restriction digestion, sequencing, and other applications. The end-user segments of this market are academic research institutes, hospitals and diagnostic centers, pharmaceutical and biotech companies, and other end users.

The product segments included in this report are enzymes, kits and reagents. The enzymes segment is divided into ligases, phosphatases, polymerases, proteases and proteinases, restriction endonucleases, reverse transcriptase, and other enzymes. The ligases segment encompasses T4 DNA ligase, thermostable DNA ligase, and other ligases. The polymerase sub-segments are high-fidelity DNA polymerase, T4 DNA polymerase, Taq DNA polymerase, and other polymerases. The restriction endonucleases enzyme segments are sub-segmented into BamHI, EcoRI, PstI, and other restriction endonucleases. The kits and reagents segment is divided into cloning and mutagenesis, nucleic acid analysis, PCR, sequencing and other kits and reagents.

The geographic segments included in this report are Asia, Europe, North America, and the Rest of the World (RoW). Asia is divided into the regional segments of China, India, Japan, and Rest of Asia. The European geographic segment is divided into the regional segments of Germany, France, Italy, Spain, the U.K., and the Rest of Europe. The North American segment includes Canada, and the U.S. The RoW segment is further divided into Latin America, Middle East and Africa, and the Pacific countries. The report maps each application, end user and product segment in 19 geographic and regional segments.

The major players in the market include Affymetrix, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Enzymatics, Inc. (U.S.), Illumina, Inc. (U.S.), New England Biolabs, Inc. (U.S.), QIAGEN, N.V. (Netherlands), Roche, Ltd. (Switzerland), Sigma-Aldrich Co. LLC. (U.S), Takara Bio, Inc. (Japan), and Thermo Fisher Scientific, Inc. (U.S.).

Key Topics Covered:

1 Introduction

2 Executive Summary

3 Market Overview

4 Global Molecular Biology Enzymes, Kits, & Reagents Market, By Application

5 Global Molecular Biology Enzymes, Kits, & Reagents Market, By End User

6 Global Molecular Biology Enzymes, Kits, & Reagents Market, By Product

7 Global Molecular Biology Enzymes, Kits, & Reagents Market, By Geography

8 Competitive Landscape

9 Company Profiles

Companies Mentioned:

  • Affymetrix
  • Agilent Technologies
  • Enzymatics
  • Illumina
  • New England Biolabs
  • Qiagen
  • Roche
  • Sigma-Aldrich Co
  • Takara Bio
  • Thermo Fisher Scientific

For more information visit

Media Contact: Laura Wood, +353-1-481-1716,

SOURCE Research and Markets
Copyright©2014 PR Newswire.
All rights reserved

Related biology technology :

1. Global Hormone Replacement Therapy Market 2014-2018: Key Vendors are Actavis, Bayer, Merck & Co, Novartis and Novo Nordisk
2. Clintrax Global, Inc. Announces Addition to Executive Team
3. Global Cell and Tissue Culture Supplies - Strategic Business Report 2014
4. Global Solid Oxide Fuel Cells (SOFCs) - Strategic Business Report 2014
5. Global Spectroscopy Equipment and Accessories - Strategic Business Report 2014
6. Linalool Industry & Diphenylamine Market (Global, China) 2014 Analysis Now Available at
7. Global HIV Infection Drug Market Overview
8. Global Life Science Reagents Market Expected to Reach USD 25.7 Billion in 2019: Transparency Market Research
9. Hospira to Present at the Morgan Stanley Global Healthcare Conference
10. Global non-GMO Food Market 2014-2018: Key Vendors are Amys Kitchen, Natures Path, Organic Valley and The Hain Celestial
11. Savory Ingredients Market by Ingredients (Yeast Extracts, HVP, HAP, MSG, Nucleotides and Others), by Application (Food Industry, Pet Food and Others) & by Geography - Global Trends & Forecasts to 2019
Post Your Comments:
(Date:11/30/2015)... (PRWEB) , ... November 30, 2015 , ... Global Stem Cells Group announced ... clinics in the cities of Arica and Iquique in northern Chile. The facilities are part ... offer the most advanced protocols and techniques in stem cell medicine to patients from around ...
(Date:11/30/2015)... /PRNewswire/ - BioAmber Inc. (NYSE: BIOA ), a leader in ... Business Act on Climate Pledge, alongside more than 140 companies ... Obama Administration to demonstrate an ongoing commitment to climate action ... COP21 Paris climate negotiations. ... Canada . --> BioAmber uses biotechnology to ...
(Date:11/30/2015)...  Culprits beware, a University at Albany research ... is taking crime scene fingerprint identification to a ... -->   --> Photo ... --> Halámek and his team ... concept for identifying whether a culprit is male ...
(Date:11/30/2015)... Nov. 30, 2015 /PRNewswire/ - Zenith Epigenetics Corp. ("Zenith" or ... Norman C.W. Wong to its Board of Directors to ... Zenith with a wealth of experience as co-founder of Resverlogix, ... --> --> Dr. Wong ... board of directors. Zenith,s long standing expertise in epigenetics and ...
Breaking Biology Technology:
(Date:11/2/2015)... , Nov. 2, 2015  SRI International has ... to provide preclinical development services to the National Cancer ... SRI will provide scientific expertise, modern testing and support ... of preclinical pharmacology and toxicology studies to evaluate potential ... --> The PREVENT Cancer Drug Development Program is ...
(Date:10/29/2015)... LA JOLLA, Calif. , Oct. 29, 2015 /PRNewswire-USNewswire/ ... released a new report titled, "DNA Synthesis and Biosecurity: ... how well the Department of Health and Human Services ... was issued in 2010. --> ... advances, but it also has the potential to pose ...
(Date:10/29/2015)... Mich. , Oct. 29, 2015  Rubicon ... Genomics for U.S. distribution of its DNA library ... kit and Rubicon,s new ThruPLEX Plasma-seq kit. ThruPLEX ... enable the preparation of NGS libraries for liquid ... for diagnostic and prognostic applications in cancer and ...
Breaking Biology News(10 mins):